Journal

Journal Information

Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others. 


Signal Transduction and Targeted Therapy is a multidisciplinary journal, covering topics including but not limited to molecular biology, cell biology, pharmacology, medicinal chemistry, computational chemistry, systems biology, bioinformatics, and clinical medicine.


The editorial team of Signal Transduction and Targeted Therapy is composed of a highly respected editorial board of researchers from across the globe, led by the internationally renowned Professor Carlo M. Croce, together with Professor Kang Zhang and Professor Yu-Quan Wei.


This journal is now indexed in Science Citation Index Expanded (SCIE), Journal Citation Reports/Science Edition, BIOSIS previews, Directory of Open Access Journals (DOAJ), MEDLINE, PubMed Central (PMC) and Scopus.


Editorial Board
Editors-in-Chief

  • Prof. Carlo M. Croce, PhD, Institute of Genetics, The Ohio State University, Columbus, Ohio, USA
  • Prof. Kang Zhang, PhD, Center for Biomedicine and Innovations at Faculty of Medicine, Macau University of Science and Technology, China
  • Prof. Yu-Quan Wei, PhD, National/State Key Laboratory of Biotherapy and Clinical Cancer Center, West China Hospital, West China Medical School, Sichuan University, China 
Associate Editors 
  • Rami I. Aqeilan, PhD, Milton Winograd Chair in Cancer Research, Lautenberg Center for Immunology and Cancer Research, Hebrew University of Jerusalem, Israel
  • Ashley Bush, PhD, University of Melbourne, Australia
  • Xuetao Cao, PhD, Chinese Academy of Medical Science, China
  • Webster K. Cavenee, PhD, Ludwig Institute for Cancer Research University of California, San Diego, USA
  • Xin-yuan Fu, PhD, National University of Singapore, Singapore
  • Guangping Gao, PhD, Microbiology and Physiological Systems, University of Massachusetts Medical School, Massachusetts, USA
  • Curtis Harris, PhD, Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, USA
  • Zhen Huang, PhD, Department of Chemistry & Department of Biology, Georgia State University, Atlanta, Georgia, USA
  • Yibin Kang, PhD, Princeton University, USA
  • Weimin Li, PhD, West China Hospital, Sichuan University, China
  • Yang Liu, PhD, Center for Cancer and Immunology Research, Children's National Medical Center, Washington DC, USA
  • Qing Richard Lu, PhD, Brain Tumor Center, Cincinnati Children's Hospital Medical Center, USA
  • Zhiyong Qian, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
  • Dalla-Favera Riccardo, PhD, Cancer Center, Columbia University; Department of Pathology & Cell Biology, Columbia University, USA
  • Hongbing Shu, PhD, Wuhan University, China
  • Shao-Cong Sun, Ph.D., The Chinese Institutes for Medical Research, China
  • Koichi Tanaka, PhD, Kyoto University, Japan
  • Philip N Tsichlis, PhD, The Ohio State University, USA
  • Peter K. Vogt, PhD, The Scripps Research Institute, USA
  • Rong Xiang, PhD, Nankai University, China
  • Zhixiong Xiao, PhD, College of Life Sciences, Sichuan University, China
  • Shengyong Yang, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China

Editorial Board Members

  • Xiuwu Bian, PhD, Armed Forces Institute of Pathology, Network Center of Third Military Medical University, Chongqing, China
  • Guojun Bu, PhD, Department of Neuroscience, Mayo Clinic, USA
  • Shawn Burgess, PhD, National Human Genome Research Institute, National Institutes of Health, USA
  • John C. Byrd, PhD, The Ohio State University, USA
  • Lulu Cai, PhD, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China 
  • George A. Calin, PhD, MD Anderson Cancer Center, USA
  • Yu Cao, PhD, West China Hospital, Sichuan University, China
  • Thomas Carell, PhD, Ludwig-Maximilians-Universität München, Germany
  • Chong Chen, PhD, West China Hospital, Sichuan University, China
  • Guoqiang Chen, PhD, School of Medicine, Shanghai Jiao Tong University, China
  • Zhijian Chen, PhD, UT Southwestern Medical Center,USA
  • Eros Lazzerini Denchi, PhD, The Scripps Research Institute, La Jolla, USA
  • Miguel Sena Esteves, PhD, University of Massachusetts Medical School, USA
  • David Fruman, PhD, University of California, Irvine, USA
  • Caiyun Fu, PhD, Zhejiang Sci-Tech University, China
  • Xiangdong Fu, PhD, Univerisity of California, San Diego, USA
  • Alan Garen, PhD, School of Medicine, Yale University, USA
  • Mark Ginsberg, PhD, University of California, San Diego, USA
  • JunLin Guan, PhD, Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, USA
  • Junhong Han, PhD, West China Hospital, Sichuan University, China
  • Stephen Hann, PhD, Vanderbilt University, Nashville, USA
  • Ming-Liang He, PhD, City University of Hong Kong, China
  • Nongyue He, PhD, School of Biological Science and Medical Engineering, Southeast University, China
  • Matthew Vander Heiden, PhD, Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, USA
  • Philip W. Hinds, PhD, Tufts University School of Medicine, USA
  • Ying Hu, PhD, Harbin Institute of Technology, China
  • Canhua Huang, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
  • Wendong Huang, PhD, Department of Diabetes Complications and Metabolism, City of Hope National Medical Center, USA
  • Shile Huang, PhD, Louisiana State University Health Sciences Center, USA
  • Peter Illes, PhD, Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, University of Leipzig, Germany
  • Lijun Jia, PhD, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, China
  • JianSheng Kang, PhD, Zhengzhou University, China
  • Tiebang Kang, PhD, Sun Yat-Sen University Cancer Center, China
  • Kazunori Kataoka, PhD, The University of Tokyo, Japan
  • Guido Kroemer, PhD, Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, France
  • Peng Lei, PhD, West China Hospital, Sichuan University, China
  • Qun-Ying Lei, PhD, Shanghai Medical College, Fudan University, China
  • Bin Li, PhD, Jinan University, China
  • Luyuan Li, PhD, State key laboratory of medicinal chemical biology, Nankai University, Tianjin, China
  • Haitao Li, PhD, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, China
  • Lei Li, PhD, MD Anderson Cancer Center, USA
  • Jinsong Li, PhD, Institute of Biochemistry and Cell Biology, Shanghai Institutes for biological Science, CAS, China
  • Guomin Li, PhD, University of Texas Southwestern Medical Center, USA
  • Wenbin Li, PhD, Beijing Tiantan Hospital, Capital Medical University, China
  • Yongsheng Li, PhD, Chongqing University Cancer Hospital, China
  • Shuo Lin, PhD, Department of Molecular, Cell & Developmental Biology, University of California, USA
  • Feng Lin, PhD, Cleveland Clinic Lerner Research Institute, USA
  • Lin Liu, PhD, College of Life Sciences, Nankai University, Tianjin, China
  • Mofang Liu, PhD, Shanghai Institute of Biochemistry and Cell Biology, CAS, China
  • Yu Liu, PhD, West China Hospital, Sichuan University, China
  • Liwei Lu, PhD, Department of Pathology, The University of Hong Kong, China
  • Nathan Luedtke, PhD, University of Zurich, Switzerland
  • Pralay Maiti, PhD, Indian Institute of Technology (Banaras Hindu University), India
  • Guido Marcucci, PhD, City of Hope Comprehensive Cancer Center, USA
  • Ruggero De Maria, PhD, Istituto Superiore di Sanita, Italy
  • Ingo Mellinghoff, PhD, Memorial Sloan-Kettering Cancer Center, USA
  • Hongming Miao, PhD, Army Medical University, China
  • Karl Munger, PhD, Tufts University School of Medicine, USA
  • Liang Ouyang, PhD, West China Hospital, Sichuan University, China
  • Liqiang Pan, PhD, Zhejiang University, China 
  • Lianghu Qu, PhD, Sun Yat-sen University, China
  • Athanasios G. Papavassiliou, PhD, Medical School, National and Kapodistrian University of Athens, Greece
  • Zihe Rao, PhD, Tsinghua University, China
  • Steve Rokita, PhD, Johns Hopkins University, USA
  • Kanaga Sabapathy, PhD, Duke University, USA
  • Alexey V. Semyanov, PhD, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Russia
  • Hubing Shi, PhD, West China Hospital, Sichuan University, China
  • Yanhong Shi, PhD, Beckman Research Institute of City of Hope，USA
  • Erwei Song, PhD, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, China
  • Xiangrong Song, PhD, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, China
  • Bing Su, PhD, Shanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, China
  • Qiu Sun, PhD, West China Hospital, Sichuan University, China
  • Ming Tan, PhD, China Medical University, Taiwan, China
  • Yongguang Tao, PhD, Central South University, China
  • David Tuveson, PhD, Cold Spring Habor Laboratory, USA
  • Henning Ulrich, PhD, Institute of Chemistry, University of São Paulo, Brazil
  • Alexei Verkhratsky, PhD, The University of Manchester, UK
  • Francesco di Virgilio, PhD, University of Ferrara, Italy
  • Daowen Wang, PhD, Huazhong University of Science and Technology, China
  • Xiaofan Wang, PhD, Duke University, USA
  • Yongsheng Wang, PhD, West China Hospital, Sichuan University
  • Min Wu, PhD, Department of Basic Sciences, University of North Dakota, USA
  • Hao Wu, PhD, Harverd Medical School and Boston Children's Hospital, USA
  • Di Xia, PhD, National Institutes of Health, USA
  • Xiao Xiao, PhD, Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, USA
  • Tian Xu, PhD, Howard Hughes Medical Institute & Yale University School of Medicine, USA
  • Xianjie Yang, PhD, UCLA School of Medicine, USA
  • Pengyuan Yang, PhD, Institutes of Biomedical Sciences, Fudan University, China
  • Dihua Yu, PhD, The University of Texas MD Anderson Cancer Center, USA
  • Junying Yuan, PhD, Department of Cell Biology，Harvard Medical School, USA
  • Qimin Zhan, PhD, State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
  • Zhiguo Zhang, PhD, Columbia University, USA
  • Shimin Zhao, PhD, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai , China
  • Pan Zheng, PhD, Children's National Medical Center, USA
  • Weimin Zhong, PhD, Yale University, USA
  • Chenchen Zhou, PhD, West China School of Stomatology, Sichuan University, China
  • Qi Zhou, PhD, State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, China
  • Weiguo Zhu, PhD, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Health Science Center, China